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The EWS-ERG fusion protein is found in human sarcomas with the chromosomal translocation t(21;22)(q22;q12), where
the translocation is considered to be an initiating event in sarcoma formation within uncommitted mesenchymal cells,
probably long-lived progenitors capable of self renewal. The fusion protein may not therefore have an oncogenic
capability beyond these progenitors. To assess whether EWS-ERG can be a tumour initiator in cells other than
mesenchymal cells, we have analysed Ews-ERG fusion protein function in a cellular environment not typical of that
found in human cancers, namely, committed lymphoid cells. We have used Ews-ERG invertor mice having an inverted
ERG cDNA cassette flanked by loxP sites knocked in the Ews intron 8, crossed with mice expressing Cre recombinase
under the control of the Rag1 gene to give conditional, lymphoid-specific expression of the fusion protein. Clonal T cell
neoplasias arose in these mice. This conditional Ews gene fusion model of tumourigenesis shows that Ews-ERG can
cause haematopoietic tumours and the precursor cells are committed cells. Thus, Ews-ERG can function in cells that do
not have to be pluripotent progenitors or mesenchymal cells.
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Introduction
Chromosomal translocations are characteristic of many
human cancers, and are especially well studied in leukaemias,
lymphomas, and sarcomas [1,2]. Epithelial tumours also carry
chromosomal translocations, but while those in leukaemias,
lymphomas, and sarcomas tend to be reciprocal trans-
locations, those in carcinomas are often non-reciprocal
translocations [3]. The main outcomes of the reciprocal
translocations are either forced oncogene expression, as
found in lymphoid malignancies, or gene fusion, found in
both leukaemias and sarcomas [1,2]. Gene fusion occurs when
the translocation breakpoints are within the introns of genes,
such that the two translocated chromosomes have new exon
organisation, leading to the formation of chimaeric mRNA
species and, in turn, chimaeric proteins.
Some translocations must function within stem cells to
initiate disease while others function in both stem cells and
more committed cells to provide related or distinct functions
(reviewed in [4]). Different tumour phenotypes can result
from speciﬁc versions of related fusion proteins, for instance,
the Philadelphia t(9;22) translocation (which yields the BCR-
ABL [breakpoint cluster region gene–Abelson leukaemia
oncogene] fusion) occurs in both myeloid- and lymphoid-
lineage tumours, dictated by the position of the translocation
junction within the BCR gene [5]. The biological consequen-
ces of the BCR-ABL fusion have been studied in relation to
stem cell properties [6–8]. These studies show that the BCR-
ABL fusion protein does not confer self-renewal potential on
committed myeloid progenitors, whereas other translocation
fusion proteins (e.g., MOZ-TIF2) do [7]. The MLL (mixed
lineage leukaemia) gene has more than 30 known fusion
partners [9,10], and retroviral transduction experiments with
MLL-ENL fusion showed that the multipotent myeloid
progenitors and committed myeloid progenitors could
respond to an MLL fusion protein to become leukaemic,
suggesting the existence of cancer stem cells distinct from
multipotent stem cells of the tissue of origin [11]. While some
translocations have these dual properties, others only
function in committed cells such as those translocations
mediated by the RAG-VDJ (recombinase activating gene and
variable, joining, diversity regions) recombinase of the
lymphoid lineage [1]. Thus, naturally occurring transloca-
tions, such as that of LMO2 (LIM domain only 2) in T cell acute
leukaemia, only function in committed cells.
Such issues are not conﬁned to haematopoietic malignan-
cies. The EWS-FUS family, typically involved in sarcoma
aetiology, exhibits characteristics of tumour initiators [12–
15]. The EWS gene, at Chromosome 22 band q12, was ﬁrst
identiﬁed in Ewing’s sarcoma by its association with FLI1 and
ATF1 [16,17] and subsequently found in subsets of Ewing’s
sarcoma with either ERG or ETV1, and E1AF and FEV [17–21].
In addition, the EWS gene is involved in other sarcomas and
with yet different partners, such as WT1 (Wilms tumour 1
gene) in desmoplastic small round cell sarcoma [22] or CHN
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Open access, freely available online PLoS BIOLOGYin myxoid chondrosarcoma [23]. A further ramiﬁcation of
this inﬁdelity is that the FUS gene, ﬁrst identiﬁed by its fusion
with the CHOP gene in t(12;16) of malignant myxoid
liposarcoma and related to the EWS gene [24,25], has also
been found in Ewing’s sarcoma fused with the ERG gene, but
also a similar FUS-ERG fusion has been described in some
acute myeloid leukaemias [26–28]. Finally, the EWS gene can
also be involved with the CHOP gene by chromosomal
translocation in malignant myxoid liposarcoma [29], analo-
gous to FUS-CHOP. The chromosomal translocations in
Ewing’s and other sarcomas are considered as primary
initiating events. Thus the EWS fusions function in the
cancer precursor cell and are required throughout tumour
formation until the emergence of the overt cancer, because
the chromosomal translocation is present in the cancer at the
time of presentation. The fusion protein may therefore be
instructive by imparting a phenotype on the cell by affecting
a speciﬁc differentiation programme, which must be part of
the genetic make-up of the cancer stem cell, since the
chromosomal translocation is an initiating and persistent
feature. The pre-existing chromosomal translocation creates
a cellular environment allowing secondary mutations to arise
in progeny cells, resulting in overt cancer. Conditional mouse
models of the EWS- and FUS-associated chromosomal trans-
locations should give insights into how these fusions inﬂuence
the malignant phenotype. We have analysed whether EWS
f u s i o n sf u n c t i o no n l yi nt he domain of mesenchymal
progenitors and whether they function in other cell lineages,
speciﬁcally within committed cells, as has been demonstrated
for MLL fusions [11].
We have developed mouse models mimicking chromosomal
translocations by employing homologous recombination in
embryonic stem (ES) cells to create mutant alleles in mice.
These methods were either the knock-in model, which
involved fusing the MLL gene partner AF9 into the mouse
Mll gene, resulting in acute myeloid leukaemias in mice
[30,31], or the translocator model [32,33] to give de novo
chromosomal translocations, resulting in cell-speciﬁc leukae-
mias [34]. We have applied a new conditional chromosomal
translocation model (designated the invertor model) [35] to
the EWS-ERG gene fusion to gain insights into the functional
signiﬁcance of the fusion protein in tumourigenesis. Invertor
mice are made by knocking a ﬂoxed cDNA cassette into the
intron of a target gene downstream of the mouse exon
equivalent to that usually involved in human chromosomal
translocations [35]. The ﬂoxed cassette is introduced into the
intron in a reverse transcriptional orientation and can be
inverted by Cre recombinase to create a transcription unit
capable of generating an appropriate fusion mRNA (see
below and Figure 1A). We have sought to determine whether
an Ews-ERG fusion can be oncogenic in a cell type not
generally associated with human tumours (speciﬁcally in
lymphoid cells) and also to determine whether Ews-ERG
fusion can initiate leukaemia from committed cells. We found
that clonal T cell lymphoma arose in the invertor model when
Cre expression was controlled by the lymphocyte-speciﬁc
Rag1 gene, showing that Ews-ERG is leukaemogenic in
lymphoid cells. Our results show that Ews-ERG can function
as an oncogene in committed cells of mice and suggest that
EWS-ERG is able to contribute to neoplasia in a variety of
cellular contexts in vivo.
Results
Conditional Inversion of the ERG Gene and Fusion with
Ews
The use of homologous recombination to generate
oncogene fusions was established with the creation of the
Mll-AF9 mouse model [30]. We attempted a similar approach
to make Ews fusions of the type found in speciﬁc human
sarcomas and leukaemias (Figure S1 shows sequences of Chop,
ATF1, and Fli1 together with AF9 sequences used for the
knock-in targeting clones). While we were able to obtain
homologous recombination knock-in clones either with a
vector carrying only a transfer cassette or with the Ews-AF9
control fusion, no clones were obtained with any of the Ews
fusions equivalent to those naturally found in human cancers
(Table S1). Furthermore, chimaeras could be made with the
Ews cassette and the Ews-AF9 knock-in (Table S1). We
concluded that Ews fusions of the type naturally associated
with human cancers could be lethal in ES cells, obviating the
generation of targeted cells.
We have recently developed a new conditional knock-in
method based on inversion of a loxP-ﬂanked cDNA cassette by
Cre recombinase [35]. This Ews-ERG invertor model is
diagrammatically shown in Figure 1A. In outline, homologous
recombination in mouse ES cells was used to introduce a
ﬂoxed ERG cDNA cassette downstream of Ews exon 7. The
cassette comprised a short intronic sequence, an acceptor
splice site, ERG cDNA, a polyA site, and a neomycin gene (to
select homologous recombinant ES cells), placed in the
opposite transcription orientation to the Ews gene. Expres-
sion of Cre recombinase inverts the cassette, bringing the
acceptor splice site into the correct orientation with the Ews
exon 7 donor splice site, to allow post-transcriptional
production of Ews-ERG fusion mRNA (Figure 1B shows the
post-inversion genomic sequence at the junction of Ews and
ERG). Targeted ES cells were injected into blastocysts, and
these yielded normal numbers of chimaeras, which gave rise
to heterozygous carriers of the Ews-ERG invertor allele
(invertor mice). In these invertor mice, Ews-ERG protein
can only be made after Cre-mediated inversion and thus can
be cell-speciﬁcally dependent on Cre expression.
The Ews-ERG Fusion Protein Causes T Cell Neoplasia in
Invertor Mice
We investigated the ability of Ews-ERG fusion protein to
contribute to leukaemogenesis by causing the inversion of the
ERG-containing cassette in lymphoid cells using Rag1-Cre
knock-in mice [36]. Out of the cohort of 29 mice carrying
both Ews-ERG and Rag1-Cre genes, 25 mice (86%) developed
leukaemia associated with thymoma within 500 d, whereas the
Ews-ERG-only cohort (20 mice) did not display neoplasia
(Figure 2). Blood smears at the time of sacriﬁce of Ews-ERG;
Rag1-Cre mice typically showed elevated numbers of large
leukocytes, with lymphoid morphology of different matur-
ities, including lymphoblasts (Figure 2). In addition, bone
marrow sections showed high levels of inﬁltrating lympho-
blasts (Figure 2). The diseased mice all had large thymomas,
usually associated with splenomegaly (Table 1) and lympha-
denopathy, and the histology of spleens showed either
complete loss of normal architecture (loss of demarcated
white and red pulp), partial loss, or normal architecture
(Figure S2). Similarly, the level of inﬁltration of leukaemic
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Ews-ERG Fusion Causes Leukaemia in Invertor Micelymphocytes into liver and kidney varied, with some having
large amounts of perivascular deposits and others marginal
levels. All mice had thymomas with homogeneous presence of
large leukaemic cells. These characteristics, together with
evidence of clonal Tcrb gene rearrangements and expression
of TCR-associated CD8 and CD4 (see below), permit diagnosis
of large cell anaplastic T cell lymphoma according to the
Bethesda proposals for lymphoid tumours in mice [37].
The Ews-ERG fusion appears crucial for malignancies in
the invertor mice, as disease only arose in mice with both the
Ews-ERG and Rag1-Cre genes (Figure 2) and comprised clonal
tumours (Figure 3). The presence of Ews-ERG mRNA was
conﬁrmed in spleens of these mice, identical with that in Ews-
ERG ES cells transfected with Cre expression plasmids (see
Figure S1). In addition, the steady state orientation of the
loxP-ﬂanked ERG cassette was studied using ﬁlter hybrid-
isation and we found that the ERG sequence had become
inverted into the 59 to 39 orientation with respect to the Ews
gene in each case of thymoma (Figure 3A; Table 1). The other
tissues examined have little evidence of an inverted band.
Finally, the presence of the Ews-ERG fusion protein was
shown by Western blotting of thymoma proteins using
antibodies binding to either Ews or ERG, which detected
respectively the normal mouse Ews or Erg proteins and the
Ews-ERG fusion molecule in thymoma T cells of an Ews-ERG;
Rag1-Cre mouse (Figure 3D).
Studies of progenitor gene expression have indicated the
promiscuous expression of lymphoid markers precedes
lineage commitment [38] and thus, the Rag1-Cre allele might
be expressing in cells destined to become non-lymphoid. The
Rag1-Cre knock-in allele was previously shown to be speciﬁc
for lymphoid cells using a reporter assay dependent on Cre-
mediated deletion of a loxP-ﬂanked (ﬂoxed) segment of the
Lmo2 gene [36]. We have sustained these observations using
an additional reporter assay, namely the ROSA-loxSTOP-lacZ
(ROSA26-R) allele [39] where b-galactosidase (bgal) expression
is activated by deletion of a loxP-pA site. Haematopoietic
populations from mice carrying both Rag1-Cre and ROSA26-R
alleles were stained with ﬂuorescent antibodies binding to
various surface markers, and ﬂow cytometry was carried out
for co-detection of antibody- and bgal-derived ﬂuorescence
(Figure S3). bgal signal was found in thymus and spleen
(almost all cells), and in bone marrow, a population of bgalþ
cells exist but did not co-express with CD34, Sca1, Ckit, or
Ter119 (or Mac1, not shown). This means that the Rag1-Cre is
restricted to lymphoid cells, as previously shown [36].
The Rag1-Cre gene is expressed in both B and T cells, but
only T cell tumours have arisen in the Ews-ERG; Rag1-Cre
invertor line. The possible inversion of the Ews-ERG gene in B
cells was investigated using RT-PCR analysis of expressed Ews-
ERG fusion mRNA (Figure 4). RNA was prepared from whole
spleen or thymus or from ﬂow-sorted B220þ spleen cells
(3,400 cells) or Thy1.2þ spleen cells (6,400 cells) and RT-PCR
performed. Pax5 and CD3 primers [38] were used for speciﬁc
Figure 1. Strategy for Generating Ews-ERG Invertor Gene by Homologous Recombination
(A) The method for making invertor mice is described in detail elsewhere [35]. In summary, an invertor cassette comprising a short intronic region with
an acceptor splice site, human ERG cDNA sequence (shown in Figure S1), a polyA site, and the MC1neopA gene all flanked by loxP sites (depicted by
black triangles) was knocked in, using homologous recombination, into Ews intron 8. The transcription orientation of the targeted ERG cDNA invertor
cassette was opposite from that of the endogenous Ews gene after initial homologous recombination. Germ line carrier mice of this targeted allele were
crossed with Cre-expressing mouse strains [36], and, as indicated in the right hand side of the diagram, the invertor cassette is turned around to create a
transcription orientation identical with that of Ews. Thus, after transcription, a pre-mRNA is made with the donor splice site of Ews exon 7 adjacent to
the acceptor site of the invertor cassette, allowing post-transcriptional fusion of Ews with ERG in an analogous format to that found in human sarcomas
with t(21;22).
(B) Genomic sequence adjacent to the Ews exon 7 and the ERG invertor cassette (the derived amino acid sequence is shown in the single letter code)
obtained from DNA of ES cells and of thymus after Cre-mediated inversion. The Ews intron 7/8 donor splice site is indicated by an arrow. The boxed
sequence (TCTAG/CGAT) corresponds to the ligation of filled-in XbaI (Ews genomic) and ClaI (ERG invertor cassette) sites (for detailed description see
[35]). The boxed XbaI site (TCTAGA) corresponds to the position of cloning of the mouse Af4 intronic sequence (shaded) in the ERG invertor cassette. On
the 39 side of the fused XbaI-ClaI sites, there is a loxP site originating from the ERG invertor cassette (see Figure S1) followed by the Af4 intron 4 (shaded)
upstream of the ERG cDNA sequence. The Af4 acceptor splice site is indicated by an arrow, and is followed by the ERG cDNA sequence. A NotI site used
for cloning the amplified ERG sequence is boxed (see also Figure S1) (note this sequence is non-contiguous and the dots represent a gap; the full
sequence appears in [35]).
DOI: 10.1371/journal.pbio.0030242.g001
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Ews-ERG Fusion Causes Leukaemia in Invertor Micedetection of B cell and T cell transcripts, respectively. Pax5
transcripts were detected in cDNA made from spleen and
B220þsorted cells, and CD3 in the spleen, thymus and thy1.2þ
sorted cells (Figure 4A and 4B). No evidence of CD3
expression was found in the sorted B220þ cells, or of Pax5
in the sorted Thy1.2þcells, showing that the sorted cells were
practically free of contaminating T or B cells, respectively.
The presence of Ews-ERG fusion RNA was analysed with RT-
PCR primers, yielding a product spanning the fusion junction
that was detected with an internal junction probe. Ews-ERG
RT-PCR product was detected in the unfractionated spleen
and thymus sources, as well as in the puriﬁed, sorted B220þ
and Thy1.2þ cells. Therefore, Cre-mediated inversion of the
Ews-ERG gene occurs in both T and B cells.
Ews-ERG Induces Malignancies of Mature T Cells
The presence of thymomas in all afﬂicted Ews-ERG; Rag1-
Cre mice suggested that the haematological malignancy in
these mice comprised T cells. This was conﬁrmed by FACS
analysis of T cell surface markers and by determination of T
cell or B cell receptor gene rearrangement status. The
majority of normal mouse thymic T cells express both the
CD4 and CD8 surface markers (double positive [DP] cells), as
well as the pan-T cell marker Thy1 (CD90) (wt in Figure 5).
The situation with the thymomas of invertor mice varied
from mainly CD4þCD8þ DP cells (e.g., M2 in Figure 5) to
mainly CD8þsingle positive (SP) cells (e.g., M3 in Figure 5) to
mainly double negative cells (e.g., M4 in Figure 5). Thirteen of
the cohort of 25 leukaemic invertor mice were analysed for
their thymic T cell proﬁle by FACS (summarized in Table 1).
While we found either CD8þSP or CD4þCD8þDP thymomas,
none showed a CD4þ SP phenotype. Two of the thymomas
had a mixed phenotype comprising mainly CD8þ SP cells,
with a sub-population of DP cells (M3 and M6 in Table 1).
The clonality of these T cell tumours was assessed by ﬁlter
hybridisation of genomic thymoma DNA with a T cell
receptor b probe (Tcrb) from the Jb2 region [40] (diagram-
matically shown in Figure 3B). The probe detects a 5-kb band
in non-lymphoid DNA corresponding to the intact Tcrb gene;
if V-D-J or D-J joins have occurred, new restriction fragments
are created, giving rise to ‘‘rearranged’’ bands on the
hybridisation autoradiograph. Figure 3B shows the rear-
rangement status of 12 of the Ews-ERG thymomas. All except
one (M9) showed at least one rearranged Jb2 allele and several
have two rearranged alleles (e.g., M18). Variable amounts of
residual germ line allele were present. The Tcrb rearrange-
ment status of the cohort of Ews-ERG leukaemic mice is
summarized in Table 1. In addition, the status of the
immunoglobulin locus was examined with a probe from the
region between JH and Cl segments [41] (see Figure 3C).
Single Igh allele rearrangements were observed in about half
of the cohort (Table 1), including ones in which FACS analysis
and Tcrb clonality hybridisations showed the tumours to be
clonal T cell malignancies. The Igh rearrangements are
therefore likely to be abortive rearrangements.
Conﬁrmation that the Tcrb rearrangements observed by
hybridisations were due to productive V-D-J joins was made
by sequence analysis of the Tcrb genes in four of the cases.
PCR ampliﬁcation from thymoma DNA was carried out with
pools of Vb primers and a Jb2 reverse primer (primer
sequences from [42,43]) and sequences identiﬁed with the
ImMunoGeneTics database [44,45]. Table 2 shows the V-D-J
junctional sequences indicating the presence of productive T
cell receptor b genes. In all cases, N-region diversity is present
between the V-D and D-J junctions. In the thymoma DNA
from M2, a non-productive join has also occurred, in addition
to the productive one, resulting in an out-of-frame joint.
Discussion
EWS-ERG Can Mediate Haematopoietic or Mesenchymal
Tumourigenesis
Human cancers of mesenchymal origin involve the EWS
gene with various partner genes, such as in the chromosomal
translocation t(21;22)(q22;q12) where EWS fuses with ERG to
encode a novel EWS-ERG fusion protein [18]. In addition,
EWS gene fusions with various partners are described in clear
cell sarcoma, desmoplastic small round cell tumours, chon-
drosarcoma, and myxoid liposarcoma, suggesting that EWS
fusion proteins are functional for various cell types of
mesenchymal origin and that restrictions in humans are
dictated largely by the cells in which the chromosomal
translocations occur. We tested the hypothesis of cell type
speciﬁcity by assessing the possible universality of EWS-ERG
as an oncogene. Our experimental system was designed to
invoke conditional, cell-speciﬁc expression of the Ews-ERG
fusion to analyse the target cell in which it can function.
Figure 2. Incidence of Haematological Malignancy and Characteristics of
Ews-ERG Invertor Mice
Cohorts of 29 Ews-ERG; Rag1-Cre mice and 20 Ews-ERG control mice
were monitored over a period of approximately 17 mo. Mice were culled
and a post-mortem conducted when signs of ill health were observed.
Leukaemia/lymphoma was established by various criteria (see Materials
and Methods). Top panel shows the survival curve of Ews-ERG; Rag1-Cre
(þCre) or Ews-ERG ( Cre) mice as a function of time (days). Bottom panel
shows the histology of blood and bone marrow from leukaemic mice
(M21 and M20, respectively). Blood smears were stained with May-
Gru ¨nwald-Giemsa stain and photographed at 4003magnification, whilst
bone marrow was photographed at 1,0003.
DOI: 10.1371/journal.pbio.0030242.g002
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Ews-ERG Fusion Causes Leukaemia in Invertor MiceConsistent EWS-ERG occurrence in human sarcomas suggests
that it may only function in mesenchymal cells, where it may
function in initiation of the cancer as well as in maintenance
of the cancer stem cell (i.e., cells within the tumour that have
self-renewing capacity and maintain the tumour). Our results
show that lymphomas arise when Ews-ERG is aberrantly
expressed in the committed cells of the lymphoid lineage.
The Ews-ERG invertor allele was activated in lymphocytes,
using the Rag1-Cre knock-in mice [36], to determine if
lymphoid malignancies would arise. We found that invertor
Ews-ERG mice develop clonal T cell malignancies. The T cells
were of varying phenotypes but the majority of cases
expressed CD8 on the cell surface and had productive V-D-
Jb rearrangements, indicative of mature T cells. Since Cre-
mediated inversion through loxP sites recreates the loxP
sequence, there is potential for the cassette to ﬂip back and
forth with continued Cre expression. This had no obvious
deleterious effect on tumourigenesis in the Ews-ERG inver-
tors as judged by various criteria (tumour penetrance,
consistent T cell phenotype, and pathology). Thus, the
invertor allele of transformed cells may be ﬁxed in the
correct orientation for synthesis of Ews-ERG mRNA when
Rag1-Cre is no longer effective. On the other hand, the lack of
CD4þ SP thymomas is difﬁcult to encompass with this
explanation, suggesting that other biological mechanisms
may be involved in this bias.
The Rag1-Cre mouse line used constitutively expresses Cre
in lymphoid cells [36], and the resulting Ews-ERG fusion
causes T lymphocyte tumours in mice, which is not known in
the spectrum of EWS-associated human cancers. On the other
hand, FUS-ERG has been found in leukaemias, albeit myeloid
type [26,46]. This implies that the EWS-FUS fusion proteins
could be effective in a spectrum of cell types, broader than
normally seen in human malignancies (i.e., sarcomas and
myeloid leukaemias). In some cells, it may be that EWS-FUS
fusions are lethal and thus those cells acquiring a trans-
location would die; in others, the fusion protein may be
tolerated and thus may become tumours. In this respect, the
absence of B cell tumours in the Ews-ERG invertors is of
interest as both B and T cells undergo inversion of the Ews-
ERG cassette (see Figure 4) because Rag1-Cre is expressed in
both cell types [36] (see Figure S3). The absence of B cell
tumours may reﬂect toxicity of the fusion protein for B cells
although this seems unlikely given that we can detect the
fusion mRNA in selected B220þB lymphocytes (see Figure 4).
Alternatively, it may mean that Ews-ERG does not function in
B cells or that the development of B cell tumours is inhibited
by the T cell malignancies, which may arise earlier and then
dominate the lymphoid compartment. The ability of Ews-
ERG to speciﬁcally cause B cell tumours could be evaluated by
using B-cell-speciﬁc Cre-expressing mouse lines such as
CD19-Cre.
Ews-ERG Can Promote Tumourigenesis in Committed
Cells
Our results show that the Ews-ERG fusion, normally
restricted to sarcomas in humans, can initiate T lymphocyte
tumours, if conditionally expressed in committed lymphoid
Table 1. Tumour Characteristics of Ews-ERG Invertor Mice Expressing Cre Recombinase from the Rag1 Gene
Mouse Number Age (Days) Postmortem Details Inversion T Cell Receptor Jb2 IgH Thymus Profile CD4/CD8
1 116 Thymoma; splenomegaly þ R/G G/G
2 119 Thymoma þ R/R G/G CD4
HI; CD8
HI
3 128 Thymoma; splenomegaly þ R/G G/G CD4 ; CD8
HI (85%) þ CD4
LO; CD8
HI (15%)
4 128 Thymoma; splenomegaly þ G/G R/G CD4 ; CD8 
5 139 Thymoma þ
a R/R R/G CD4 ; CD8
HI
6 149 Thymoma þ R/R G/G CD4 ; CD8
HI (75%) þ CD4
LO; CD8
HI (20%)
7 173 Thymoma þ R/R R/R
8 173 Thymoma þ R/R R/G
9 179 Thymoma; splenomegaly þ G/G G/G
10 183 Thymoma þ R/R G/G
11 183 Thymoma; splenomegaly þ R/G G/G CD4 ; CD8
LO
12 208 Thymoma; splenomegaly þ R/G R/-
13 216 Thymoma þ R/R G/G CD4 ; CD8
HI
14 222 Thymoma; splenomegaly þ R/R R/G CD4 ; CD8
HI
15 264 Thymoma; splenomegaly þ
a R/G G/G CD4 ; CD8
HI
16 273 Thymoma; splenomegaly þ R/R R/R
17 286 Thymoma; splenomegaly þ R/G G/G CD4 ; CD8
HI
18 298 Thymoma þ
a R/R R/G
19 311 Thymoma þ R/G R/R
20 353 Thymoma þ R/G G/G CD4 ; CD8
HI
21 405 Thymoma þ R/R G/G
22 405 Thymoma þ
a R/G R/G CD4 ; CD8-
23 438 Thymoma þ R/G R/G
24 447 Thymoma þ R/G G/G CD4 ;CD8
LO
25 494 Thymoma þ
a R/G G/G
A cohort of 29 Ews-ERG; Rag1-Cre mice was established and monitored for ill health. Of these mice, 25 developed lymphoma within the observation period. The main post-mortem characteristics (including the age in days to disease
manifestation) are shown. The status of the ERG cassette was determined by filter hybridisation to ascertain that the transcription orientation was 59 to 39 (inverted) with respect to the Ews gene in the thymoma DNA; A plus sign under
Inversion indicates that ERG cassette inversion was found in thymoma DNA. T cell receptor b gene (TCRJb2 [40]) and Igh (heavy-chain intron l enhancer probe [41]) rearrangements were determined by filter hybridisation of thymoma DNA.
The cell surface CD4 and CD8 protein expression profile in the thymomas was determined using flow cytometry.
aHas a small residual un-inverted allele thymoma.
G, germ line; R, rearranged.
DOI: 10.1371/journal.pbio.0030242.t001
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Ews-ERG Fusion Causes Leukaemia in Invertor Micecells. Leukaemogenesis in Ews-ERG invertor mice thus
concurs with the hypothesis that EWS fusions can cause
neoplasia arising in various cell types. Further, our data imply
that the cellular context of EWS-associated chromosomal
translocations in humans does not have to be a stem cell or
even a multi-potent progenitor, as committed lymphocyte
precursors expressing Rag recombinase genes are the
leukaemic precursors in our invertor model. The same
conclusions can be applied to FUS-associated chromosomal
translocations that seem to be largely interchangeable with
EWS, given the spectrum of cancers in which these are found
and the relatedness of FUS- and EWS-coded proteins [24,25].
Thus, EWS or FUS chromosomal translocations probably arise
more by virtue of accessibility of the genes to chromosomal
translocations than by the precise cellular speciﬁcity of the
resultant fusion proteins.
Materials and Methods
Generation of targeting constructs and homologous recombina-
tion. The Ews genomic targeting clone was constructed from c phage
DNA isolated from mouse 129 DNA [47]. The knock-in clones for
potential Ews fusions with AF9, Fli1, Chop, and ATF1 were made using
a transfer vector pC2A-neo [35], and the sequences of these cDNA
cassettes are given in Figure S1. Knock-in was achieved by
homologous recombination as described [47]. The ERG inversion
knock-in cassette [35] was prepared using cDNA made from human
colon carcinoma COLO320 mRNA (the sequence of the ERG segment,
corresponding to the part of ERG found in EWS-ERG fusion [19] is
shown Figure S1). A diagram of overall structure of the ERG inversion
cassette is shown in Figure 1A, indicating the initial orientation of
Figure 3. Clonality of T Cell Neoplasias in Ews-ERG Invertor Mice
Genomic DNA was prepared from various tissues of invertor mice with
thymomas. Genomic analysis was carried out using filter hybridisation to
assess the presence of the inverted ERG cassette in the tumour cells (A),
and to assess whether the lymphocytes involved in the tumours were
clonal T (B) or B cells (C).
(A) Inversion hybridisation autoradiograph. DNA was prepared from the
thymoma and other tissues of M18, cleaved with EcoRI and hybridised to
the 59 Ews probe (which detects a 5-kb targeted ERG cassette fragment
or a 6.5-kb Cre-inverted fragment). If the ERG cassette is inverted by Cre
activity, the size of the EcoRI fragment increases from the initial targeted
gene size, as indicated in the maps below the figure. The data shown are
for DNA extracted from spleen (spl), thymus (thy), liver (liv), kidney (kid)
or tail (ES cell DNA is used as a control). The Cre-mediated inverted band
(;6.5 kb) is evident in thymus DNA (thymoma). The summary of the data
from the cohort of invertor mice is in Table 2. Note that despite extensive
infiltration of spleen detected by histology, we cannot see the inverted
band by Southern blot; this presumably reflects regional clustering of
neoplastic cells in spleen. Restriction fragment sizes are represented as
germ line (GL), inverted allele of ERG cassette (inv) and initial targeted
Ews allele (Tgt). The organisation of the targeted Ews allele is indicated
underneath. The hybridisation autoradiograph shows the location of Ews
exon 7 and the initial targeted orientation (bottom) or inverted
orientation of ERG invertor cassette after Cre-mediated recombination
(top). a, acceptor splice site.
(B) Autoradiograph showing rearrangement of T cell receptor b locus. A T
cell receptor Jb2 probe [40] (diagrammatically shown below the
autoradiograph) detects a 5-kb germ line HindIII Jb2 band whilst V-D-
Jb2 joins in T cells result in new HindIII-sized bands depending on the
nature of the rearrangement. Each of 12 thymoma DNAs that were
compared showed one or two Jb2 alleles rearranged, signifying that
these tumours were clonal T cells. In some thymoma samples, there is
almost complete absence of the germ line band, indicating that the
Figure 4. B and T Cells Express the Ews-ERG Fusion RNA
A 96-d-old mouse with both Ews-ERG and Rag1-Cre alleles was used as a
source of spleen and thymus cells. Single cell suspensions of spleen cells
were labelled with anti-B220 or with anti-Thy1.2 and were purified using
a MoFlo preparative flow cytometer. Estimated purities were achieved of
greater than 95%. cDNA was prepared from RNA extracted from sorted
cells or from aliquots of unsorted populations and RT-PCR (approx-
imately 3,400 B220þ or 6,400 Thy1.2þ cell equivalents per PCR reaction)
carried out with specific Pax5 (A), CD3 (B) or Ews-ERG (C) primers. PCR
reaction products were fractionated on 1% agarose gels and either
stained with ethidium bromide and photographed (A and B) or gel
blotted and hybridised with an Ews-ERG probe (C)
DOI: 10.1371/journal.pbio.0030242.g004
thymuses of these mice are solely comprised of malignant clonal T cells.
DNA sequence analysis of the V-D-J junctions of mice M2, M5, M13, and
M18 showed functional V-D-J joins (see Table 2).
(C) Autoradiograph showing rearrangement status of immunoglobulin
heavy-chain genes. A Cl intron probe [41] (diagrammatically shown
below the autoradiograph) was used to hybridise a set of thymoma
DNAs for the presence of Igh rearranged bands. Only two samples
showed rearrangements.
(D) Detection of Ews-Erg fusion protein in thymoma cells. Single cell
suspensions were made of T cells from a normal thymus (wt) or from the
thymoma of M6, protein fractionated on 4%–20% acrylamide gel, and
transferred to nylon membranes. Specific proteins were detected with
anti-Ews or anti-ERG antibody.
DOI: 10.1371/journal.pbio.0030242.g003
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determined by restriction site mapping and genomic DNA sequenc-
ing. After identiﬁcation of targeted ES cells, these were injected into
C57BL/6 blastocysts, chimaeric mice were produced, and germ line
transmission of the inversion knock-in allele was obtained. These
mice were bred with mice expressing Cre from a Rag1 knock-in [36].
Speciﬁcity of expression of the Rag1-Cre allele has previously been
described [36] and was sustained using the ROSA26-R reporter mice
[39] (see Figure S3).
Molecular analyses. Genomic DNA was prepared from tissues using
proteinase K digestion and phenol-chloroform extraction, and ﬁlter
hybridisations were carried out with radiolabelled probes as
described [48,49]. The probes used to detect antigen receptor gene
rearrangements were a heavy-chain Ig l intron enhancer probe [41]
and a T cell receptor Jb2 probe [40]. T cell receptor V-D-Jb junction
sequences were obtained by PCR ampliﬁcation from thymoma DNA
with pools of Vb primers and a Jb2 reverse primer (primer sequences
from [42,43]), and the product was fractionated on agarose to
determine the presence of a single ampliﬁed band. In turn, each band
was eluted and the sequence obtained using the Jb2N primer [43] and
identiﬁed by comparison with the ImMunoGeneTics database [44,45].
RT-PCR was carried out on cDNA as described [34]. RNA was
prepared using RNeasy (Quiagen, Valencia, California, United States)
from cells that were labelled with FITC-conjugated antibodies and
isolated by ﬂow cytometry. Sequences have been described for Pax5
and CD3 RT-PCR primers [38], and the sequences of the Ews-ERG
primers were 59-CCACAGGATGGTAACAAGCCTGC-39 (Ews) and 59-
CGAACTTGTAGGCGTAGC-39 (ERG). The hybridisation probe was a
303-bp fragment of Ews-ERG residing within the RT-PCR product.
Analysis of leukaemia/lymphoma. A cohort of mice was established
by inter-breeding the Ews-ERG invertor line with a Rag1-Cre line [36]
to generate littermates with Ews-ERG þ Rag1-Cre or Ews-ERG
genotypes. Genotypes were determined using ﬁlter hybridisation of
genomic DNA from a small tail biopsy. The health status of these
mice was monitored, and if signs of ill health appeared, mice were
sacriﬁced and a post-mortem was carried out. Tissue samples were
removed for single cell preparation for determination of surface
protein expression phenotype, for nucleic acid preparation, or for
ﬁxation in 10% formalin for histology. Blood smears were prepared
and stained with May-Gru ¨nwald-Giemsa. For histology, ﬁxed tissues
were embedded in wax and 0.4-l sections made, stained with
haematoxylin and eosin after mounting on slides. FACS analysis
was conducted using a FACSCalibur with ﬂuorescent antibodies
purchased from BD Biosciences (San Jose, California, United States).
Data were analysed with CellQuest software (BD Biosciences).
Western protein detection was carried out as described [36] using
18 lg of protein per lane and proteins fractionated on 4%–20% SDS-
PAGE. The separated proteins were electro-transferred to PVDF
nylon membranes (Millipore, Billerica, Massachusetts, United States)
and speciﬁc proteins detected using anti-Ews antibody (Santa Cruz
Biotechnology, Santa Cruz, California, United States; raised against
the amino terminus of Ews) or anti-ERG antibody (Santa Cruz
Biotechnology; raised against the carboxy terminus of ERG). Anti-
body bound to ﬁlter was detected using secondary antibodies and
ECL as described by the manufacturer (Amersham Biosciences,
Amersham, United Kingdom).
Supporting Information
Figure S1. Sequence of Mouse FliI RT-PCR Fragment
Found at DOI: 10.1371/journal.pbio.0030242.sg001 (111 KB PDF).
Figure S2. Histological Characteristics of Leukaemias in Ews-ERG
Invertor Mice
Found at DOI: 10.1371/journal.pbio.0030242.sg002 (6.4 MB PDF).
Figure S3. ROSA26-R-bgal Reporter Assay for Expression of Rag1-Cre
Allele
Found at DOI: 10.1371/journal.pbio.0030242.sg003 (354 KB PDF).
Table S1. Frequency of Targeted Clones and Chimaera Generation
with Ews Knock-In ES Clone
Found at DOI: 10.1371/journal.pbio.0030242.st001 (23 KB DOC).
Table 2. Sequences of Rearranged TCR Jb Loci in Ews-ERG Thymoma DNA.
Mouse
Number
Vb
Primer
Pool
Vb Db Jb Productive
or Non-
Productive
Sequence of V-D-Jb2 rearrangement
M2 2 þ 11
þ 15
VB16
unclear
DB1
DB2
JB2.4
JB2.2
P
NP
TGTGCAAGCAGCTGGGACACTAGTCAAAACACCTTGTACTTTGGTGCGGGCACCCGA
TGTGCCAGCATTTCCAGGACTGTG
M5 5 þ 13 VB4 DB1 JB2.5 P TGTGCCAGCAGTGGCGACAGGGGG CAAGACACCCAGTACTTTGGGCCAGGCACTCGG
M13 4 þ 8 þ
14
VB8 DB1
or 2
JB2.3 P TGTGCCAGCGGTGAGAAACCGGGGACAGCTAGTGCAGAAACGCTGTATTTTGGCTCAGGAACCAGA
M18 6 þ 12 VB19 DB2 JB2.5 P TGTGCCAGCAGTCCCCACTGGGGGGGGAACCAAGACACCCAGTACTTTGGGCCAGGCACTCGG
Thymoma DNAs Were Prepared from Ews-ERG; Rag1-Cre mice and the V-D-Jb2 rearrangements were analysed (Figure 5 and summary Table 1). The rearranged V-D-Jb2 segments were amplified by PCR using primer pairs previously described
[42,43] and the pools of Vb primers (as indicated) with the single Jb2 primer. Amplification was assayed using agarose gel electrophoresis (not shown), and the PCR products were directly sequenced using the Jb2N primer. Assignment of
sequences was accomplished by comparison with those in the ImMunoGeneTics database [44]. V, D, or J segments are underlined and nucleotides between them represent N-region additional nucleotides.
NP, non-productive V-D-J join resulting in out of frame joint; P, productive V-D-J join.
DOI: 10.1371/journal.pbio.0030242.t002
Figure 5. Analysis of Cell Surface Antigens of Thymomas from Ews-ERG
Invertor Mice Using Flow Cytometry
Thymus tissue was resected from mice with thymoma and FACS analysis
performed to determine T cell phenotype (summarised in Table 1). The
data in the figure show representative flow diagrams of three tumour-
bearing mice (M2, M3, and M4) compared with a wild-type C57BL/6
control (wt), using anti-Thy1 (y-axis) plus anti-B220 (x-axis) antibodies or
using anti-CD8 (y-axis) plus anti-CD4 (x-axis) antibodies. The three
thymomas show a range of CD4 and CD8 co-expression phenotypes
characterizing the thymomas generated in the Ews-ERG; Rag1-Cre
invertor mice..
DOI: 10.1371/journal.pbio.0030242.g005
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